The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology
- PMID: 1637251
- DOI: 10.1001/archpsyc.1992.01820080023004
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology
Abstract
The Comprehensive Assessment of Symptoms and History was developed for research studies of schizophrenia spectrum conditions and affective spectrum conditions. It is designed to provide a comprehensive information base concerning current and past signs and symptoms, premorbid functioning, cognitive functioning, sociodemographic status, treatment, and course of illness. Because the information base is broad, it is not wedded to a specific diagnostic system but rather permits clinicians and investigators to make diagnoses using a wide range of systems, including Research Diagnostic Criteria, DSM-III, DSM-III-R, and the International Classification of Diseases. Given the fact that disorders in psychiatry are not defined at the etiological or pathophysiological level, diagnostic criteria are prone to ongoing revision as our knowledge base changes. Research strategies suggest that investigators should maintain a flexible database to permit them to adapt to changes in diagnostic systems, to do comparative nosological studies, and, ultimately, to develop new diagnostic systems based on knowledge concerning the underlying neurobiological nature of disorders. Because it provides a comprehensive information base, the Comprehensive Assessment of Symptoms and History facilitates research of this type. Extensive developmental work has been done with the Comprehensive Assessment of Symptoms and History, including interrater and test-retest reliability studies, validity studies, training programs, and data entry programs.
Similar articles
-
An empirical comparison of diagnoses and reliabilities in ICD-10 and DSM-III-R.Eur Arch Psychiatry Clin Neurosci. 1993;242(4):209-17. doi: 10.1007/BF02189965. Eur Arch Psychiatry Clin Neurosci. 1993. PMID: 8461347
-
The reliability of DSM-III prodromal symptoms in first-episode psychotic patients.Acta Psychiatr Scand. 1994 Nov;90(5):375-8. doi: 10.1111/j.1600-0447.1994.tb01609.x. Acta Psychiatr Scand. 1994. PMID: 7872043
-
Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity.Compr Psychiatry. 1995 Jul-Aug;36(4):241-50. doi: 10.1016/s0010-440x(95)90068-3. Compr Psychiatry. 1995. PMID: 7554867
-
The diagnosis of schizophrenia: a review of onset and duration issues.Schizophr Bull. 1991;17(1):51-67. doi: 10.1093/schbul/17.1.51. Schizophr Bull. 1991. PMID: 2047789 Review.
-
Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales.World J Biol Psychiatry. 2009;10(1):6-26. doi: 10.1080/15622970802264606. World J Biol Psychiatry. 2009. PMID: 18663668 Review.
Cited by
-
Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale.Int J Methods Psychiatr Res. 2012 Dec;21(4):286-300. doi: 10.1002/mpr.1362. Epub 2012 Sep 10. Int J Methods Psychiatr Res. 2012. PMID: 22961922 Free PMC article.
-
General and social cognition in remitted first-episode schizophrenia patients: a comparative study.Eur Arch Psychiatry Clin Neurosci. 2016 Oct;266(7):639-47. doi: 10.1007/s00406-016-0701-x. Epub 2016 Jun 1. Eur Arch Psychiatry Clin Neurosci. 2016. PMID: 27250978
-
Building a neurocognitive profile of suicidal risk in severe mental disorders.BMC Psychiatry. 2022 Sep 26;22(1):628. doi: 10.1186/s12888-022-04240-3. BMC Psychiatry. 2022. PMID: 36162995 Free PMC article.
-
Gesture Performance in Schizophrenia Predicts Functional Outcome After 6 Months.Schizophr Bull. 2016 Nov;42(6):1326-1333. doi: 10.1093/schbul/sbw124. Epub 2016 Aug 27. Schizophr Bull. 2016. PMID: 27566843 Free PMC article.
-
Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.Schizophr Bull. 2013 Jul;39(4):848-56. doi: 10.1093/schbul/sbs067. Epub 2012 Apr 24. Schizophr Bull. 2013. PMID: 22532702 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous